COVID-19

Data from new trials from the United Kingdom and Brazil show positive high-level results regarding AstraZeneca’s COVID-19 vaccine candidate.

Soon after Pfizer announced the results of its phase 3 trial on its COVID-19 vaccine candidate, there arose some questions around the vaccine’s storage.

Two new studies explored the COVID-19-related death rates in New York and in England.

The COVID-19 pandemic has further magnified the racial/ethnic disparities present in the US health care system. In a recent study, the researchers examined the relationship of racial/ethnic differences,...

This randomized control trial investigated whether mask wearing can prevent SARS-CoV-2 infection. However, the findings do not mean masks should not be worn, the researchers noted.

Pfizer and BioNTech have reported results from a phase 3 trial of their mRNA-based coronavirus vaccine candidate, BNT162b2. Read more about the efficacy here.

Moderna has announced that results of a phase 3 study show that the company’s mRNA-1273 vaccine is safe and effective.

Pfizer has released details from its first interim efficacy analysis of results from the current phase 3 trial of its COVID-19 vaccine candidate.

This COVID-19 roundup details the results of a recent study that examined how long antibodies remained detectable following disease onset, as well as a study which found that aspirin use could significantly...

The FDA has approved the first option for the treatment of adult and pediatric patients aged 12 years or older with COVID-19 who require hospitalization.